In addition, a new peptide, known as the Ft peptide, could synergistically target glioma-associated TN-C and neuropilin-1 in the neovasculature, circumventing the tumor's pathologic ECM barrier, and achieving deep penetration into the glioma parenchyma for anti-GBM treatment (64). The gene discussed is TNC; the disease is glioblastoma.